Lawsuits alleging that prenatal use of the pain reliever acetaminophen caused children to develop autism or ADHD will be transferred to New York, according to a judicial panel’s order on Wednesday.
The U.S. Judicial Panel on Multidistrict Litigation, in its order, combined 65 lawsuits into a single proceeding over the objections of the defendants, which are nine retailers, including CVS, Walgreens, Target and Walmart. Although acetaminophen is most commonly known as Tylenol, which is sold by Johnson & Johnson, the lawsuits target retailers and their generic brands, instead.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
